Skip to content

Drug interactions

Atogepant + Ticagrelor

Severity: Minor

Atogepant and Ticagrelor: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ticagrelor is a weak CYP3A4 inhibitor and atogepant is a CYP3A4 substrate, so atogepant exposure may rise modestly. This is generally of limited clinical importance.

What this interaction means in plain words

Atogepant and Ticagrelor have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Atogepant belongs to Central Nervous System; Ticagrelor belongs to Cardiovascular.

Evidence level: Low

Why it happens

Weak inhibition of CYP3A4 by ticagrelor reduces atogepant metabolism.

What to do

No dose change is usually needed; monitor for atogepant adverse effects such as constipation or nausea.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Atogepant and Ticagrelor, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Atogepant with Ticagrelor?

MediHelp rates the interaction as minor. Atogepant and Ticagrelor have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ticagrelor is a weak CYP3A4 inhibitor and atogepant is a CYP3A4 substrate, so atogepant exposure may rise modestly. This is generally of limited clinical importance.

How serious is the interaction between Atogepant and Ticagrelor?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is usually needed; monitor for atogepant adverse effects such as constipation or nausea.

What other medicines interact with Ticagrelor?

MediHelp also lists interactions of Ticagrelor with, for example, Itraconazole, Ketoconazole, Levoketoconazole. The full list is on the Ticagrelor page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in